Latest Breaking News On - Sophia bashford - Page 1 : comparemela.com

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral Treatment, at doses used for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Baden wübergCzech republicUnited statesSouth africaSwitzerland generalHans erikssonMckenna millerSophia bashfordDevelco pharmaKetabon gmbhHome administrationBrain healthKetabon programHolding gmbProlonged release oral ketamine formulationFinds less incidence

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression

Ketabon GmbH Reports Top-Line Results from Phase 2 Trial of Take-at-Home, Oral Ketamine Option for Treatment-Resistant Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Czech republicSwitzerland generalBaden wübergSouth africaAnne donohoeSophia bashfordHans erikssonMartin walterDevelco pharmaHolding gmbBrain healthKetabon programUniversity jenaHead of the department psychiatryGmbh reports top line resultsOral ketamine option

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H C Wainwright & Co 4th Annual Neuropsychiatry Conference

HMNC Brain Health to Participate in the Psychedelic Science Conference 2023 and the H C Wainwright & Co 4th Annual Neuropsychiatry Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesColorado convention centerAnne donohoeDaniel gehrlachSophia bashfordStrategic communicationsHc wainwright coBrain healthHolding gmbBrain health toPsychedelic science conferenceAnnual neuropsychiatryScience conferenceComputational approachesDrug discoveryMile high

HMNC Brain Health Begins Phase 2 Study for Personalized

HMNC Brain Health Begins Phase 2 Study for Personalized
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Sophia bashfordHans erikssonAnne donohoeMaximilian doeblerBrain healthHolding gmbMajor depressive disorderChief business officerChief medical officerTreatment resistant depression

HMNC Brain Health Begins Phase 2 Study for Personalized Treatment of Stress-Axis Related Major

MUNICH, Germany, June 20, 2023 (GLOBE NEWSWIRE) HMNC Brain Health (‘‘HMNC’’ or the ‘‘Company’’), a global clinical-stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced today

Hans erikssonSophia bashfordAnne donohoeMaximilian doeblerHolding gmbBrain healthMajor depressive disorderChief business officerChief medical officerTreatment resistant depression